Device Tms Neurohealth Centers INC.

Tms Neurohealth Centers INC.

Payments companies reported to CMS as associated with Tms Neurohealth Centers INC.. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$34Kassociated payments (2023-2025)
1,156clinicians with associated payments
1company reporting

By year

2025 $34K

Payments reported as associated with Tms Neurohealth Centers INC., per program year, as reported to CMS.

Who makes it

Specialties most often involved

Psychiatric/Mental Health (Nurse Practitioner) $9,445
Psychiatry $4,673
Family $4,037
Family Medicine $3,510
Physician Assistant $3,088
Internal Medicine $3,003

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Tms Neurohealth Centers INC.

These are the largest totals companies reported as associated with Tms Neurohealth Centers INC.. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Stephanie Dang Austin, TX Psychiatric/Mental Health (Nurse Practitioner) $203.28
Karine Toumanian Trumbull, CT Internal Medicine $157.60
Olayemi Olajuyigbe Elkridge, MD Psychiatric/Mental Health (Nurse Practitioner) $148.95
Murray Snook Leander, TX Family Medicine $147.15
Patrick Gagnon Milford, CT Psychiatric/Mental Health (Nurse Practitioner) $143.59
Anna Gut Trumbull, CT Psychiatric/Mental Health, Adult (Clinical Nurse Specialist) $143.59
Shannon Mohabir Bridgeport, CT Internal Medicine $143.59
Soha Alammoury Dearborn Heights, MI Psychiatric/Mental Health (Nurse Practitioner) $142.17
Tony Singh Detroit, MI Psychiatry $142.17
Ammar Ali Dearborn, MI Psychiatry $142.17

Prescribed Tms Neurohealth Centers INC.?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.